ArticleInsect biochemistry and molecular biology2026
A genome sequence and efficient CRISPR/Cas9 gene editing tools for the solanaceous specialist pest Tetranychus evansi.
Article in Insect biochemistry and molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tetranychus evansi is an invasive spider mite pest of solanaceous crops worldwide. Its rapid global spread and ability to develop acaricide resistance highlight the need for robust genomic resources and functional genetic tools for custom control strategies. Here, we present a genome assembly and establish efficient CRISPR/Cas9 editing in T. evansi to enable mechanistic studies of host adaptation and pesticide resistance. Using an inbred line and Oxford Nanopore Technologies long-read sequencing, we assembled an 89 Mb genome into 13 contigs (N50 = 18.6 Mb) and annotated 14,246 protein-coding genes. Manual curation of detoxification gene families (P450s, CCEs, GSTs, UGTs, ABC transporters and DOGs), revealed smaller repertoires than in the polyphagous relative Tetranychus urticae. To enable reverse genetics, we adapted SYNCAS for maternal delivery of CRISPR/Cas9 in T. evansi. Targeting the phytoene desaturase (PD) pigmentation marker produced reliable knockouts with visible lack of red pigmentation and editing efficiencies of ∼10-15%, allowing the efficient creation of stable mutant lines. We further applied precision gene editing to knock-in (KI) the M918T and M918L substitutions into the voltage-gated sodium channel (VGSC). While M918L was lethal in T. evansi, we generated multiple homozygous lines for M918T (KI efficiency ∼ 4.4%). Bioassays demonstrated that while the mutation caused extremely high levels of bifenthrin resistance (RR = 345-645), this was less so for β-cyfluthrin (RR = 113-127), deltamethrin (RR = 58.2-65.6) and tau-fluvalinate (RR = 87.7-98), revealing the specific role of M918T in pyrethroid resistance. Collectively, these resources establish T. evansi as a tractable system for reverse genetic analysis and provide a reference for future comparative and population genomics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.